Media

Bioscience industry a bright spot among the technology sector
The 2014 BIO International Convention, where the global biotech community meets, connecting the people, companies and innovations that help to fulfill the...

Press Releases

Apr 14 2000
WASHINGTON, D.C. (April 14, 2000) The BiotechnologyIndustry Organization (BIO) has put together a coalition of entrepreneurial associations to support full...
Apr 13 2000
WASHINGTON (APRIL 13, 2000)-- We commend the work of the House subcommittee report which encompasses the research and testimony of distinguished scientists who...
Apr 12 2000
WASHINGTON, D.C., (April 12, 2000) Nancy Bradish Myers, health-care policy and reimbursement counsel for the Biotechnology Industry Organization (BIO), issued...
Apr 5 2000
(Dr. Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization (BIO) today made the following comments in response to...
Apr 5 2000
WASHINGTON (April 5, 2000) Recommendations put forth today in a National Research Council report entitled Genetically Modified Pest Protected Plants: Science...
Apr 5 2000
WASHINGTON, D.C. (April 5, 2000) The Biotechnology Industry Organization (BIO) applauded President Clinton for comments today clarifying his March 14 joint...
Apr 4 2000
WASHINGTON (April 3, 2000) The Biotechnology Industry Organization (BIO) today announced as chairman of the board of directors, Mark Skaletsky, president and...
Apr 4 2000
(Carl B. Feldbaum, president of BIO, today issued the following statement regarding a request by Reps. Dennis Kucinich (D-Ohio) and Jack Metcalf (R-Wash.) to...
Apr 3 2000
Washington - April 3, 2000 - A multi-year, industry-led public information program begins today to share information about agricultural biotechnology with...


Biotechnology News

July 23, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2014 fourth-quarter conference call on Wednesday...

July 23, 2014

FRAMINGHAM, Mass.--(BUSINESS WIRE)--rEVO Biologics, Inc., a subsidiary of LFB Biotechnologies, today announced the enrollment of the first patient in its Phase 3 clinical...

July 23, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today announced top-line results from RELIEF, a randomized, double-blind clinical trial designed to...

July 23, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended June 30, 2014. Total revenues...

July 23, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina Reports Strong Results for Second Quarter of Fiscal Year 2014